View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0920-1453
ICR Reference No:
202504-0920-030
Status:
Active
Previous ICR Reference No:
202410-0920-005
Agency/Subagency:
HHS/CDC
Agency Tracking No:
0920-1453-25-0109
Title:
[NCCHPHP] Comprehensive Evaluations of the WISEWOMAN Programs, The National Cardiovascular Health Program, The Innovative Cardiovascular Health Program
Type of Information Collection:
No material or nonsubstantive change to a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
05/09/2025
Retrieve Notice of Action (NOA)
Date Received in OIRA:
05/01/2025
Terms of Clearance:
Inventory as of this Action
Requested
Previously Approved
Expiration Date
12/31/2027
12/31/2027
12/31/2027
Responses
316
0
316
Time Burden (Hours)
484
0
484
Cost Burden (Dollars)
0
0
0
Abstract:
The purpose of the project is to conduct a comprehensive implementation and outcome evaluation to assess the unique contributions of The National Cardiovascular Health Program (The National CVH Program), The Innovative Cardiovascular Health Program (The Innovative CVH Program), and Well-Integrated Screening and Evaluation of Women Across the Nation (WISEWOMAN) cooperative agreements to identify promising cardiovascular disease (CVD) prevention and management practices that can be scaled and replicated, advance health equity, and the transformation of health systems for improved CVD prevention and management. The programs work together to create efficiencies and improve outcomes in jurisdictions that receive funding for two or more of the cooperative agreements. This Evaluation aims to assess implementation, assess the extent to which short-term, intermediate, and long-term outcomes have been met, and estimate the costs involved in program implementation. This Non-Substantive Change Request is submitted to revise questions to align with recent executive orders, EO 14168 and EO 14151. There is no change anticipated to the currently approved burden hours.
Authorizing Statute(s):
US Code:
42 USC 247b
Name of Law: Project grants for Preventive Health Services
US Code:
42 USC Title IV, Sec. 4002, 300u-11
Name of Law: Affordable Care Ac, Prevention and Helath Fund
US Code:
42 USC Title XV, Sec. 1509
Name of Law: Public Health Service Act
US Code:
42 USC Sec. 1502, 3001
Name of Law: Public Health Service Act
PL:
Pub.L. 117 - 328 136 STAT. 4459
Name of Law: An Act
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
89 FR 38151
05/07/2024
30-day Notice:
Federal Register Citation:
Citation Date:
89 FR 88778
11/08/2024
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
32
IC Title
Form No.
Form Name
Comprehensive Evaluation Resource Use and Cost Inventory Tool_Partner (Attachment 5b)
0920-24FI
Cost Study – Partner Interview Guide
Comprehensive Evaluation Resource Use and Cost Inventory Tool_Recipient (Attachment 5a)
0920-24FI
Comprehensive Evaluation Resource Use and Cost Inventory Tool (Recipient)
Cost Study Interview Guide_Partner (Attachment 5d)
0920-1453
Att 5d. Cost Study_Interview Guide_Partners_rev 2025
Cost Study Interview Guide_Recipient (Attachment 5c)
0920-24FI
Cost Study – Recipient Interview Guide
Eval Assessment CCL Partner Interview Guide NCHP_ICHP (Attachment 3n)
0920-1453
Att 3n. Eval Assessment_CCL_Partner_Interview Guide_NCHP_ICHP_rev 2025
Eval Assessment CCL Partner Interview Guide WW (Attachment 3o)
0920-1453
Att 3o. Eval Assessment_CCL_Partner_Interview Guide_WW_rev 2025
Eval Assessment CCL Recipient Interview Guide NCHP_ICHP (Attachment 3l)
0920-1453
Att 3l. Eval Assessment_CCL_Recipient_Interview Guide_NCHP_ICHP_rev 2025
Eval Assessment CCL Recipient Interview Guide WW (Attachment 3m)
0920-1453
Att 3m. Eval Assessment_CCL_Recipient_Interview Guide_WW_rev 2025
Eval Assessment CQM Partner Interview Guide NCHP_ICHP (Attachment 3f)
0920-1453
Att 3f. Eval Assessment_CQM_Partner_Interview Guide_NCHP_ICHP_rev 2025
Eval Assessment CQM Partner Interview Guide WW (Attachment 3g)
0920-1453
Att 3g. Eval Assessment_CQM_Partner_Interview Guide_WW_rev 2025
Eval Assessment CQM Recipient Interview Guide NCHP_ICHP (Attachment 3d)
0920-1453
Att 3d. Eval Assessment_CQM_Recipient_Interview Guide_NCHP_ICHP_rev 2025
Eval Assessment CQM Recipient Interview Guide WW (Attachment 3e)
0920-1453
Att 3e. Eval Assessment_CQM_Recipient_Interview Guide_WW_rev 2025
Eval Assessment LC Interview Guide_NCHP_ICHP (Attachment 3c)
0920-1453
Att 3c. Eval Assessment_LC_Interview Guide_NCHP_ICHP_rev 2025
Eval Assessment TBC Partner Interview Guide NCHP_ICHP (Attachment 3j)
0920-1453
Att 3j. Eval Assessment_TBC_Partner_Interview Guide_NCHP_ICHP_rev 2025
Eval Assessment TBC Partner Interview Guide WW (Attachment 3k)
0920-1453
Att 3k. Eval Assessment_TBC_Partner_Interview Guide_WW_rev 2025
Eval Assessment TBC Recipient Interview Guide NCHP_ICHP (Attachment 3h)
0920-1453
Att 3h. Eval Assessment_TBC_Recipient_Interview Guide_NCHP_ICHP_rev 2025
Eval Assessment TBC Recipient Interview Guide WW (Attachment 3i)
0920-1453
Att 3i. Eval Assessment_TBC_Recipient_Interview Guide_WW_rev 2025
Evaluability Assessment Nomination Form_NCHP_ICHP (Attachment 3a)
0920-1453
Att 3a. Evaluability Assessment Nomination Form_NCHP_ICHP_rev 2025
Evaluability Assessment Nomination Form_WW (Attachment 3b)
0920-1453
Att 3b. Evaluability Assessment Nomination Form_WW_rev 2025
Ex Assessment CCL Partner Interview Guide NCHP_ICHP (Attachment 4l)
0920-1453
Att 4l. Ex Assessment_CCL_Partner_Interview Guide_NCHP_ICHP_rev 2025
Ex Assessment CCL Partner Interview Guide_WW (Attachment 4m)
0920-1453
Att 4m. Ex Assessment_CCL_Partner_Interview Guide_WW_rev 2025
Ex Assessment CCL Recipient Interview Guide NCHP_ICHP (Attachment 4j)
0920-1453
Att 4j. Ex Assessment_CCL_Recipient_Interview Guide_NCHP_ICHP_rev 2025
Ex Assessment CCL Recipient Interview Guide_WW (Attachment 4k)
0920-1453
Att 4k. Ex Assessment_CCL_Recipient_Interview Guide_WW_rev 2025
Ex Assessment CQM Partner Interview Guide NCHP_ICHP (Attachment 4d)
0920-1453
Att 4d. Ex Assessment_CQM_Partner_Interview Guide_NCHP_ICHP_rev 2025
Ex Assessment CQM Partner Interview Guide_WW (Attachment 4e)
0920-1453
Att 4e. Ex Assessment_CQM_Partner_Interview Guide_WW_rev 2025
Ex Assessment CQM Recipient Interview Guide NCHP_ICHP (Attachment 4b)
0920-1453
Att 4b. Ex Assessment_CQM_Recipient_Interview Guide_NCHP_ICHP_rev 2025
Ex Assessment CQM Recipient Interview Guide_WW (Attachment 4c)
0920-1453
Att 4c. Ex Assessment_CQM_Recipient_Interview Guide_WW_rev 2025
Ex Assessment LC Interview Guide NCHP_ICHP (Attachment 4a)
0920-1453
Att 4a. Ex Assessment_LC_Interview Guide_NCHP_ICHP_rev 2025
Ex Assessment TBC Partner Interview Guide NCHP_ICHP (Attachment 4h)
0920-1453
Att 4h. Ex Assessment_TBC_Partner_Interview Guide_NCHP_ICHP_rev 2025
Ex Assessment TBC Partner Interview Guide_WW (Attachment 4i)
0920-1453
Att 4i. Ex Assessment_TBC_Partner_Interview Guide_WW_rev 2025
Ex Assessment TBC Recipient Interview Guide NCHP_ICHP (Attachment 4f)
0920-1453
Att 4f. Ex Assessment_TBC_Recipient_Interview Guide_NCHP_ICHP_rev 2025
Ex Assessment TBC Recipient Interview Guide_WW (Attachment 4g)
0920-1453
Att 4g. Ex Assessment_TBC_Recipient_Interview Guide_WW_rev 2025
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
316
316
0
0
0
0
Annual Time Burden (Hours)
484
484
0
0
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
No
Burden Increase Due to:
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
Annual Cost to Federal Government:
$708,783
Does this IC contain surveys, censuses, or employ statistical methods?
No
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
No
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
No
Agency Contact:
Jeffrey Zirger 404 639-7118 wtj5@cdc.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
05/01/2025